Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neurogene (NGNE) Other Operating Expenses: 2019

Historic Other Operating Expenses for Neurogene (NGNE) over the last 1 years, with Dec 2019 value amounting to $52.1 million.

  • Neurogene's Other Operating Expenses rose 5186.54% to $5.5 million in Q1 2020 from the same period last year, while for Mar 2020 it was $52.7 million, marking a year-over-year change of. This contributed to the annual value of $52.1 million for FY2019, which is N/A change from last year.
  • As of FY2019, Neurogene's Other Operating Expenses stood at $52.1 million.
  • In the past 5 years, Neurogene's Other Operating Expenses ranged from a high of $52.1 million in FY2019 and a low of $52.1 million during FY2019.
  • Moreover, its 1-year median value for Other Operating Expenses was $52.1 million (2019), whereas its average is $52.1 million.